ABCG2 and cancer: A straightforward approach of blocking ABC transporters activity to counter drug resistance in cancer had focused on using competitive inhibitors that bind to the transporter with at least the same affinity as the drug, thereby preventing cellular detoxification and leading to intracellular drug accumulation (1–3, 27, 28).